At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 294 enrolled
Drug / intervention
ADPS topical product +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel-group Study to Evaluate the Efficacy and Safety of ADPS in the Treatment of Acne Vulgaris
In Brief
A Phase 2 clinical trial evaluating ADPS topical product and Placebo Control for Acne Vulgaris. Completed, enrolled 294 participants.
Detailed Summary
Safety and efficacy study in patients with acne vulgaris
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedOct 2016
Primary CompletionJan 2017
Study CompletionMar 2017
TodayJul 2026
First PostedOct 17, 2016
Enrollment StartOct 3, 2016
Primary CompletionJan 24, 2017
Study CompletionMar 21, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.7 years ago
Interventions
ADPS topical productdrug
topical product
Placebo Controldrug
topical product